The Japanese toxicogenomics project: Application of toxicogenomics

Molecular Nutrition and Food Research

Volumn 54, Issue 2, 2010, Pages 218-227

  Uehara, Takeki ^a,b   Ono, Atsushi ^b,c   Maruyama, Toshiyuki ^a   Kato, Ikuo ^a   Yamada, Hiroshi ^b   Ohno, Yasuo ^b,c   Urushidani, Tetsuro ^b,d  

^a SHIONOGI AND CO LTD   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^d DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

Author keywords

Genomic biomarker; Hepatotoxicity; Microarray; Toxicogenomics; Toxicogenomics project

Indexed keywords

PHARMACOLOGICAL BIOMARKER;

ANIMAL; DRUG APPROVAL; DRUG DEVELOPMENT; DRUG INDUSTRY; GENE EXPRESSION PROFILING; GENETIC DATABASE; HUMAN; INTERNATIONAL COOPERATION; JAPAN; METHODOLOGY; REVIEW; RISK ASSESSMENT; SPECIES DIFFERENCE; TOXICITY TESTING; TOXICOGENETICS;

ANIMALS; BIOMARKERS, PHARMACOLOGICAL; DATABASES, GENETIC; DRUG APPROVAL; DRUG DISCOVERY; DRUG INDUSTRY; GENE EXPRESSION PROFILING; HUMANS; INTERNATIONAL COOPERATION; JAPAN; RISK ASSESSMENT; SPECIES SPECIFICITY; TOXICITY TESTS; TOXICOGENETICS;

EID: 76749102991     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200900169     Document Type: Review

References (38)

1. Ismail, K., Landis, J., Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. 2003, 3, 711-715.
2. Edgar, R., Domrachev, M., Lash, A. E., Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002, 30, 207-210.
3. Barrett, T., Troup, D. B., Wilhite, S. E., Ledoux, P. et al., NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res. 2009, 37, D885-D890.
4. Brazma, A., Parkinson, H., Sarkans, U., Shojatalab, M. et al., ArrayExpress - a public repository for microarray gene expression data at the EBI. Nucleic Acids Res. 2003, 31, 68-71.
5. Parkinson, H., Kapushesky, M., Kolesnikov, N., Rustici, G. et al., ArrayExpress update - from an archive of functional genomics experiments to the atlas of gene expression. Nucleic Acids Res. 2009, 37, D868-D872.
6. Ikeo, K., Ishii, J., Tamura, T., Gojobori, T. et al., CIBEX: center for information biology gene expression database. C. R. Biol. 2003, 326, 1079-1082.
7. Hayes, K. R., Vollrath, A. L., Zastrow, G. M., McMillan, B. J. et al., EDGE: a centralized resource for the comparison, analysis, and distribution of toxicogenomic information. Mol. Pharmacol. 2005, 67, 1360-1368.
8. Waters, M., Stasiewicz, S., Merrick, B. A., Tomer, K. et al., CEBS Chemical Effects in Biological Systems: a public data repository integrating study design and toxicity data with microarray and proteomics data. Nucleic Acids Res. 2008, 36, D892-D900.
9. Burgoon, L. D., Zacharewski, T. R., dbZach toxicogenomic information management system. Pharmacogenomics 2007,8,287-291.
10. Mattingly, C. J., Colby, G. T., Forrest, J. N., Boyer, J. L., The Comparative Toxicogenomics Database (CTD). Environ. Health Perspect. 2003, 111, 793-795.
11. Mattingly, C. J., Rosenstein, M. C., Colby, G. T., Forrest, Jr, J. N. et al., The Comparative Toxicogenomics Database (CTD): a resource for comparative toxicological studies. J. Exp. Zoolog. A Comp. Exp. Biol. 2006, 305, 689-692.
12. Mulrane, L., Rexhepaj, E., Smart, V., Callanan, J. J. et al., Creation of a digital slide and tissue microarray resource from a multi-institutional predictive toxicology study in the rat: an initial report from the PredTox group. Exp. Toxicol. Pathol. 2008, 60, 235-245.
13. McBurney, R. N., Hines, W. M., Von Tungeln, L. S., Schnackenberg, L. K. et al., The liver toxicity biomarker study: phase I design and preliminary results. Toxicol. Pathol. 2009, 37, 52-64.
14. Porter, M. W., Castle, A. L., Orr, M. S., Mendrick, D. L., in: Burczynski, M. E. (Ed.), Predictive Toxicogenomics: An Introduction to Toxicogenomics, CRC Press, Boca Raton 2003, pp. 225-260.
15. Tibshirani, R., Hastie, T., Narasimhan, B., Chu, G., Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl. Acad. Sci. USA 2002, 99, 6567-6572.
16. Brown, M. P., Grundy, W. N., Lin, D., Cristianini, N. et al., Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc. Natl. Acad. Sci. USA 2000, 97, 262-267.
17. Kiyosawa, N., Shiwaku, K., Hirode, M., Omura, K. et al., Utilization of a one-dimensional score for surveying chemical-induced changes in expression levels of multiple biomarker gene sets using a large-scale toxicogenomics database. J. Toxicol. Sci. 2006, 31, 433-448.
18. Uehara, T., Kiyosawa, N., Hirode, M., Omura, K. et al., Gene expression profiling of methapyrilene-induced hepatotoxicity in rat. J. Toxicol. Sci. 2008, 33, 37-50.
19. Uehara, T., Kiyosawa, N., Shimizu, T., Omura, K. et al., Species-specific differences in coumarin-induced hepatotoxicity as an example toxicogenomics-based approach to assessing risk of toxicity to humans. Hum. Exp. Toxicol. 2008,27,23-35.
20. Kiyosawa, N., Uehara, T., Gao, W., Omura, K. et al., Identification of glutathione depletion-responsive genes using phorone-treated rat liver. J. Toxicol. Sci. 2007, 32, 469-486.
21. James, L. P., Mayeux, P. R., Hinson, J. A., Acetaminophen-induced hepatotoxicity. Drug Metab. Dispos. 2003, 31, 1499-1506.
22. Kiyosawa, N., Ito, K., Sakuma, K., Niino, N. et al., Evaluation of glutathione deficiency in rat livers by microarray analysis. Biochem. Pharmacol. 2004, 68, 1465-1475.
23. Hirode, M., Ono, A., Miyagishima, T., Nagao, T. et al., Gene expression profiling in rat liver treated with compounds inducing phospholipidosis. Toxicol. Appl. Pharmacol. 2008, 229,290-299.
24. Hirode, M., Horinouchi, A., Uehara, T., Ono, A. et al., Gene expression profiling in rat liver treated with compounds inducing elevation of bilirubin. Hum. Exp. Toxicol. 2009, 28, 231-244.
25. Uehara, T., Hirode, M., Ono, A., Kiyosawa, N. et al., A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats. Toxicology 2008, 250, 15-26.
26. Ellinger-Ziegelbauer, H., Gmuender, H., Bandenburg, A., Ahr, H. J., Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies. Mutat. Res. 2008, 637, 23-39.
27. Ellinger-Ziegelbauer, H., Stuart, B., Wahle, B., Bomann, W., Ahr, H. J., Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. Mutat. Res. 2005, 575, 61-84.
28. Fielden, M. R., Brennan, R., Gollub, J., A gene expression biomarker provides early prediction and mechanistic assessment of hepatic tumor induction by nongenotoxic chemicals. Toxicol. Sci. 2007, 99, 90-100.
29. Nie, A. Y., McMillian, M., Parker, J. B., Leone, A. et al., Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity. Mol. Carcinog. 2006, 45, 914-933.
30. Fielden, M. R., Nie, A., McMillian, M., Elangbam, C. S., Interlaboratory evaluation of genomic signatures for predicting carcinogenicity in the rat. Toxicol. Sci. 2008, 103, 28-34.
31. Tamura, K., Ono, A., Miyagishima, T., Nagao, T. et al., Profiling of gene expression in rat liver and rat primary cultured hepatocytes treated with peroxisome proliferators. J. Toxicol. Sci. 2006, 31, 471-490.
32. Vassallo, J. D., Hicks, S. M., Daston, G. P., Lehman-McKeeman, L. D., Metabolic detoxification determines species differences in coumarin-induced hepatotoxicity. Toxicol. Sci. 2004, 80, 249-257.
33. Felter, S. P., Vassallo, J. D., Carlton, B. D., Daston, G. P., A safety assessment of coumarin taking into account species-specificity of toxicokinetics. Food Chem. Toxicol. 2006,44,462-475.
34. Vassallo, J. D., Hicks, S. M., Daston, G. P., Lehman-McKeeman, L. D., Metabolic detoxification determines species differences in coumarin-induced hepatotoxicity. Toxicol. Sci. 2004, 80, 249-257.
35. Felter, S. P., Vassallo, J. D., Carlton, B. D., Daston, G. P., A safety assessment of coumarin taking into account species-specificity of toxicokinetics. Food Chem. Toxicol. 2006,44,462-475.
36. Born, S. L., Hu, J. K., Lehman-McKeeman, L. D., o-Hydro-xyphenylacetaldehyde is a hepatotoxic metabolite of coumarin. Drug Metab. Dispos. 2000, 28, 218-223.
37. Born, S. L., Caudill, D., Smith, B. J., Lehman-McKeeman, L. D., In vitro kinetics of coumarin 3,4-epoxidation: application to species differences in toxicity and carcinogenicity. Toxicol. Sci. 2000, 58, 23-31.
38. Lake, B. G., Investigations into the mechanism of coumarin-induced hepatotoxicity in the rat. Arch. Toxicol. 1984, 7, 16-29.